ANNETTE KARENA REGAN (MCCLAVE), PhD, MPH, MInfDis

210 Adriance Lab Drive, College Station TX 77433 · 979.436.9396 regan@tamhsc.edu · annetteregan.com · @AnnetteKRegan

POSITIONS

SEPT 2018 – PRESENT ASSISTANT PROFESSOR, SCHOOL OF PUBLIC HEALTH, TEXAS A&M UNIVERSITY

JAN 2018 – SEPT 2018 NHMRC EARLY CAREER RESEARCH FELLOW, SCHOOL OF PUBLIC HEALTH, CURTIN UNIVERSITY

NOV 2016 – DEC 2017 RESEARCH FELLOW, SCHOOL OF PUBLIC HEALTH, CURTIN UNIVERSITY

AUG 2016 – NOV 2016 EPIDEMIOLOGIST, PREVENTION & CONTROL TEAM, COMMUNICABLE DISEASE CONTROL DIRECTORATE, DEPARTMENT OF HEALTH WESTERN AUSTRALIA

MAY 2016 – NOV 2016 EPIDEMIOLOGICAL POSTDOCTORAL RESEARCH FELLOW, GROUP A STREPTOCOCCAL DISEASES, TELETHON KIDS INSTITUTE

JUL 2013 – AUG 2016 SENIOR PROJECT OFFICER, PREVENTION & CONTROL TEAM, COMMUNICABLE DISEASE CONTROL DIRECTORATE, DEPARTMENT OF HEALTH WESTERN AUSTRALIA

APR 2011 – DEC 2012 CONSULTANT EPIDEMIOLOGIST, MCKING CONSULTING

AUG 2007 – APR 2011 EPIDEMIOLOGIST, OFFICE ON SMOKING AND HEALTH, CENTERS FOR DISEASE CONTROL & PREVENTION

MAY 2006 – AUG 2007 HEALTHCARE ANALYST II, NORTHROP GRUMMAN

AUG 2004 – MAY 2006 BEHAVIOR DATA SPECIALIST, MARCUS AUTISM CENTER

EDUCATION

SEPT 2016 DOCTOR OF PHILOSOPHY, UNIVERSITY OF WESTERN AUSTRALIA

SEPT 2016 MASTERS OF INFECTIOUS DISEASES, UNIVERSITY OF WESTERN AUSTRALIA

JUNE 2006 MASTER OF PUBLIC HEALTH (EPIDEMIOLOGY), EMORY UNIVERSITY

JULY 2004

BACHELORS OF SCIENCE (PSYCHOLOGY), UNIVERSITY OF FLORIDA

2

PUBLICATIONS

PEER-REVIEWED PUBLICATIONS:

1. REGAN A, Gissler M, Magnus CM, Håberg S, Malacova E, Nassar NN, Leonard H, Pereira G. Adverse birth outcomes associated with interpregnancy interval among women with a previous stillbirth: an international cohort study. Lancet; in press [Accepted 7 Sep 2018].

2. REGAN AK, Ball SJ. Warren JL, Malacova E, Marston C, Nassar N, Leonard H, de Klerk N, Pereira G. The uncertain role of interpregnancy interval and why we need new approaches to an old problem. American Journal of Epidemiology 2018; in press [Accepted 11 August 2018].

3. REGAN AK, Ball SJ, Warren JL, Malacova E, Padula A, Marston C, Nassar N, Stanley F, Leonard H, de Klerk N, Pereira G. A population-based matched sibling analysis estimating the association between first interpregnancy interval and birth outcomes. American Journal of Epidemiology 2018; in press [Accepted 4 July 2018].

4. Thompson MG, Kwong JC, REGAN AK, Katz M, Drews SJ, Azziz-Baumgartner E, Klein NP, Chung H, Feldman B, Simmonds K, Wyant BE, Dawood FS, Jackson ML, Levy A, Barda N, Svenson LW, Fink RV, Ball SW, Naleway A, on behalf of PREVENT workgroup. Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016. Clinical Infectious Diseases 2018; in press [Accepted 26 June 2018].

5. Gebremedhin A, REGAN AK, Malacova E, Ball SJ, Foo D, Pereira G. Effects of interpregnancy interval on pregnancy complications: protocol for systematic review and meta-analysis. BMJ Open 2018; in press [Accepted 7 June 2018].

6. REGAN AK, Klein NP, Langley G, Drews SJ, Buchan S, Ball S, Kwong JC, Naleway A, Thompson M, Wyant BE, Levy A, Chung H, Feldman B, Katz M. Respiratory syncytial virus hospitalization during pregnancy in four high-income countries, 2010-2016. Clinical Infectious Diseases 2018; in press. [Accepted 12 May 2018].

7. REGAN AK, Gibbs RA, Effler PV. An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice. Vaccine 2018; 36(23):3195-3198.

8. REGAN AK, Hauck Y, Nicolau L, Engelbrecht D, Butt J, Mak DB, Priest R, Cukierman R, Effler PV. Midwives’ knowledge, attitudes and learning needs regarding antenatal vaccination. Midwifery 2018; 62:199-204.

9. Lotter K, REGAN AK, Thomas T, Effler PV, Mak DB. Antenatal influenza and pertussis vaccine uptake among Aboriginal mothers in Western Australia. Australia & New Zealand Journal of Obstetrics & Gynaecology 2017;58(4):417-24.

10. REGAN AK, Bloomfield L, Peters I, Effler PV. Randomized controlled trial of text message reminders for increasing influenza vaccination. Annals of Family Medicine 2017; 15(6): 507-14. Citations: 2

11. REGAN AK, Moore HC, Sullivan SG, de Klerk N, Effler PV. Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes. Epidemiology & Infection 2017; 145(14): 2930-9. Citations: 1

12. Pereira G, Lee HJ, Bell M, REGAN AK, Malacova E, Mullins B, Knibbs L. Development of a model for particulate matter pollution in Australia with implications for other satellite-based models. Environmental Research 2017; 159: 9-15. Citations: 1

13. Malacova E, REGAN AK, Nassar N, Raynes-Greenow C, Leonard H, Srinivasjois R, Shand A, Lavin T, Pereira G. Risk of stillbirth, preterm delivery and fetal growth restriction following exposure in previous birth: systematic review and meta-analysis. British Journal of Obstetrics & Gynecology 2017;125(2):183-92.

3

14. REGAN AK, Moore HC, de Klerk NC, Mak DB, Omer SB, Effler PV. Reply to Levi et al. Clinical Infectious Diseases 2017; 64(8): 1143-4.

15. REGAN AK, Mak DB, Thomas T, Effler PV. Seasonal influenza vaccination in Aboriginal children in Western Australia in 2015. Australian Family Physician 2016; 45(10): 641-642.

16. Fielding JE, Levy A, Chilver MB, Deng Y, REGAN AK, Grant KA, Stocks NP, Sullivan SG. Effectiveness of seasonal influenza vaccine in Australia, 2015: an epidemiological, antigenic and phylogenetic assessment. Vaccine 2016; 34(41): 4905-4912. Citations: 1

17. REGAN AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study. Pediatric Infectious Disease Journal 2016; 35(10): 1097-1103. Citations: 11

18. REGAN AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended respiratory infections in pregnant women: a retrospective cohort study. Vaccine 2016; 34(32):3649-3656. Citations: 5

19. Sullivan S, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, Levy A, Stocks NP, Tempone SS, REGAN AK. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Epidemiology & Infection 2016; 144(11);2317-2328. Citations: 11

20. REGAN AK, Tracey LE, Blyth CC, Richmond PC, Effler PV. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy. Vaccine 2016; 34(20);2299-2304. Citations: 9

21. REGAN AK, Moore HC, de Klerk N, Omer SB, Mak DB, Effler PV. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clinical Infectious Diseases 2016; 62(10);1221-1227. Citations: 12

22. REGAN AK, Mak DB, Hauck YL, Gibbs R, Tracey LE, Effler PV. Trends in seasonal influenza vaccine uptake during pregnancy in Western Australia: implications for midwives. Women and Birth 2016; 29(5): 423-429. Citations: 9

23. Fielding JE, REGAN AK, Dalton CB, Chilver MB, Sullivan SG. How severe was the 2015 influenza season in the Australian community? Medical Journal of Australia 2016; 204(2): 60-61. Citations: 9

24. Pillsbury A, Cashman P, Leeb A, REGAN AK, Westphal D, Snelling T, Blyth C, Crawford N, Wood N, Macartney K. Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015. Eurosurveillance 2015; 29(43): 30050. Citations: 10

25. REGAN AK, Mak DB, Moore HC, Tracey L, Saker R, Jones C, Effler PV. Surveillance of antenatal influenza vaccination: validity of current systems and recommendations for improvement. BMC Public Health 2015; 15: 1155. Citations: 4

26. REGAN AK, Tracey L, Gibbs R. Post-marketing surveillance of adverse events following immunization with inactivated quadrivalent and trivalent influenza vaccines in health care providers in Western Australia. Vaccine 2015; 33(46): 6149-6151. Citations: 9

27. Carcione D, REGAN AK, Tracey L, Mak DB, Gibbs R, Dowse GK, Bulsara M, Effler PV. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine 2015; 33(42): 5654-5661. Citations: 18

28. REGAN AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, Talbot C, Effler PV. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnancy women. BMC Pregnancy & Childbirth 2015; 15: 61. Citations: 12

29. REGAN AK, Blyth CC, Tracey L, Mak DB, Richmond PC, Effler PV. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation. Vaccine 2015; 33(31): 3689-3694. Citations: 3

4

30. Tracey LE, REGAN AK, Mak DB, Effler PV. Adverse events following influenza immunization reported by healthcare personnel using active surveillance based on text messages. Infection Control & Hospital Epidemiology 2015; 36(5): 608-610. Citations: 4

31. Mak DB, REGAN AK, Joyce S, Gibbs R, Effler PV. Antenatal care provider’s advice is the key determinant of influenza vaccination uptake in pregnant women. Australia & New Zealand Journal of Obstetrics & Gynaecology 2015; 55(2): 131-137. Citations: 21

32. Tracey LE, REGAN AK, Armstrong PK, Dowse GK, Effler PV. EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease. Eurosurveillance 2015; 20(1): 20999. Citations: 23

33. REGAN AK, Blyth CC, Mak DB, Richmond PC, Effler PV. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Australia & New Zealand Journal of Obstetrics & Gynaecology 2014; 54(6): 522-528. Citations: 12

34. Levy A, Sullivan SG, Tempone SS, Wong KL, REGAN AK, Dowse GK, Effler PV, Smith DW. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. Vaccine 2014; 32(47): 631-638. Citations: 18

35. Blyth CC, Richmond PC, Jacoby P, Thornton P, REGAN AK, Robins C, Kelly H, Smith DW, Effler PV. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. Vaccine 2014; 32(32): 4075-4081. Citations: 16

36. Leeb A, REGAN AK, Peters IJ, Leeb C, Leeb G, Effler PV. Using automated text messages to monitor adverse events following immunisation in general practice. Medical Journal of Australia 2014; 200(7): 416-418. Citations: 24

37. REGAN AK, Blyth CC, Effler PV. Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Medical Journal of Australia 2013; 199(11): 744-746. Citations: 9

38. REGAN AK, Dube SR, Arrazola R. Smokeless and flavored tobacco products in the U.S.: 2009 Styles survey results. American Journal of Preventive Medicine 2012; 42(1): 29-36. Citations: 48

39. REGAN AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tobacco Control 2013; 22(1): 19-23. Citations: 372

40. Davis SP, MCCLAVE-REGAN AK, Rock VJ, Kruger J, Garrett BE. Perceptions of menthol cigarette use among U.S. adults and adult smokers: findings from the 2009 HealthStyles survey. Nicotine & Tobacco Control Research 2010; 12(Suppl 2): S125-S135. Citations: 10

41. MCCLAVE-REGAN AK, Berkowitz J. Smokers who are also using smokeless tobacco products in the US: a national assessment of characteristics, behaviours and beliefs of ‘dual users’. Tobacco Control 2011; 20(3): 239-242. Citations: 60

42. Thorne S, MCCLAVE AK, Rock V, Asman K, Malarcher A. Any tobacco use in 13 states – Behavioral Risk Factor Surveillance System. MMWR Morbidity & Mortality Weekly Report 2010; 59(30): 946-950. Citations: 15

43. MCCLAVE AK, Rock V, Thorne S, Malarcher A. State-specific prevalent of cigarette smoking and smokeless tobacco use among adults – United States, 2009. MMWR Morbidity & Mortality Weekly Report 2010; 59(43): 1400-1406. Citations: 96

44. Dube SR, MCCLAVE AK, James C, Caraballo R, Kaufmann R, Pechacek T. Vital signs: current cigarette smoking among adults ≥18 years – United States, 2009. MMWR Morbidity & Mortality Weekly Report 2010; 59(35): 1135-1140. Citations: 122

5

45. MCCLAVE AK, McKnighty-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. American Journal of Public Health 2010; 100(12): 2464-2472. Citations: 182

46. MCCLAVE AK, Hogue CJ, Brunner-Huber LR, Ehrlich AC. Cigarette smoking women of reproductive age who use oral contraceptives: results from the 2002 and 2004 Behavioral Risk Factor Surveillance Systems. Women Health Issues 2010; 20(6): 380-385. Citations: 16

47. MCCLAVE AK, Whitney N, Thorne SL, Mariolis P, Dube SR, Engstrom M. Adult tobacco survey – 19 states, 2003-2007. MMWR Surveillance Summary 2010; 59(3): 1-75. Citations: 557

48. Dube SR, Caraballo RS, Dhingra SS, Pearson WS, MCCLAVE AK, Strine TW, Berry JT, Mokdad AH. The relationship between smoking status and serious psychological distress: findings from the 2007 Behavioral Risk Factor Surveillance System. International Journal of Public Health 2009; 54(Suppl 1): 68-74. Citations: 43

49. MCCLAVE AK, Dube SR, Strine TW, Kroenke K, Caraballo RS, Mokdad AH. Associations between smoking cessation and anxiety and depression among U.S. adults. Addictive Behavior 2009; 34(6-7): 491-497. Citations: 101

50. MCCLAVE AK, Dube SR, Strine TW, Mokdad AH. Associations between health-related quality of life and smoking status among a large sample of U.S. adults. Preventive Medicine 2009; 48(2): 173-179. Citations: 53.

INVITED COMMENTARY:

51. REGAN AK. Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects. Evidence Based Nursing 2017; 159: 9-15.

52. Wiley K, REGAN AK, McIntyre P. Immunisation in pregnancy – the who, what, when and why. Australian Prescriber 2017; 40: 122-4.

53. REGAN AK. The safety of maternal immunization. Human Vaccines & Immunotherapeutics 2016; 12(12): 3132-3136. Citations: 5

54. REGAN AK. Why every pregnant woman should get a flu vaccine. Medicus 2016; 56(6): 42-43.

LETTERS TO THE EDITOR:

55. REGAN AK, Moore HC, Sullivan SG. Does influenza vaccination during early pregnancy really increase the risk of miscarriage? Vaccine 2018;36(17):2227-8.

CONFERENCE PARTICIPATION

INTERNATIONAL CONFERENCES - ORAL PRESENTATIONS SELECTED FROM ABSTRACT:

1. REGAN AK, Pereira G, Effler PV. Text message reminders from general practice improve seasonal influenza vaccine coverage. World Congress on Public Health. Melbourne VIC; 5 April 2017.

2. REGAN AK, Sullivan SS, de Klerk N, Moore HC, Effler PV. Burden of seasonal influenza in pregnant women. Options IX for the Control of Influenza. Chicago IL; 25 August 2016. *Late breaker oral presentation*

3. REGAN AK, Moore HC, de Klerk N, Effler PV. Effectiveness of maternal influenza vaccination in a population-based cohort. Options IX for the Control of Influenza. Chicago, IL; 26 August 2016.

4. REGAN AK, de Klerk N, Moore HC, Effler PV. Fetal loss and seasonal influenza vaccination during pregnancy. Options IX for the Control of Influenza. Chicago, IL; 26 August 2016.

6

5. REGAN AK, Moore HC, Effler PV. Burden of seasonal influenza infection among pregnant women. Incidence, Severity and Impact of Influenza 2016; Paris, France; 22 January 2016.

6. REGAN AK, de Klerk N, Effler PV. Use of linked data to evaluate the safety and effectiveness of maternal influenza vaccination. Farr Institute International Conference 2015. St Andrews, Scotland; 28 August 2015.

7. REGAN AK, Peters I, Gibbs R, Effler PV. Using electronic health records to estimate seasonal influenza vaccine effectiveness. 20th International Epidemiology Association World Congress of Epidemiology. Anchorage, AK; 17 August 2014.

NATIONAL CONFERENCES - ORAL PRESENTATIONS SELECTED FROM ABSTRACT:

8. REGAN AK, Pereira G, Effler PV. Safety of inactivated influenza vaccination in first trimester of pregnancy in an Australian population-based cohort study. Canadian Immunization Conference, Ottawa; 4-6 Dec 2018.

9. REGAN AK, de Klerk N, Moore HC, Effler PV. Self-controlled case series investigating the association between influenza vaccination and miscarriage. Perth, Western Australia; 23-26 October 2018.

10. REGAN AK, Thompson M, Kwong JC, Katz M, Drews SJ, Azziz-Baumgartner E, Klein N, Chung H, Effler PV, Feldman B, Simmonds K, Wyant B, Dawood F, Jackson M, Levy A, Barda N, Svenson L, Fink R, Ball S, Naleway A. Pregnancy Vaccine Effectiveness Network (PREVENT): multi-country cohort study estimating influenza vaccine effectiveness. 16th PHAA National Immunisation Conference, Adelaide SA; 5 June 2018.

11. REGAN AK, Effler PV, Thomson C, Mak D. Using Midwives Notification data to monitor antenatal influenza and pertussis vaccination uptake. 16th PHAA National Immunisation Conference, Adelaide SA; 6 June 2018.

12. REGAN AK, Pereira G, Effler PV. Birth outcomes associated with seasonal influenza vaccination during first trimester of pregnancy. 2018 Annual Congress of the Perinatal Society of Australia and New Zealand. Auckland, New Zealand; 26-28 March 2018.

13. REGAN AK, Gissler M, Magnus C, Håberg S, Ball SJ, Malacova E, Nassar N, Leonard H, Pereira G. An international cohort study measuring adverse birth outcomes associated with interpregnancy interval following stillbirth. 2018 Annual Congress of the Perinatal Society of Australia and New Zealand. Auckland, New Zealand; 26-28 March 2018. *awarded best oral presentation in epidemiology*

14. REGAN AK, Moore HC, Effler PV. Non-influenza respiratory virus infections during pregnancy and their impact on perinatal health. Australian Respiratory Virology Meeting. Melbourne VIC; 3 November 2017.

15. REGAN AK, Mak DB, Thomson C, Effler PV. Surveillance of antenatal pertussis and influenza vaccination uptake in Western Australia. 2017 Communicable Disease Control Conference. Melbourne, VIC; 27 June 2017.

16. REGAN AK, Gissler M, Håberg S, Magnus CM, Ball SJ, Malacova E, Marston C, Padula A, Nassar NN, Pereira G. Establishing a multi-country birth cohort to measure interpregnancy interval effects. 2017 Scientific Meeting of the Australasian Epidemiology Association. Sydney NSW; 28-30 September 2017.

17. REGAN AK, Ball SJ, Malacova E, Marston C, Nassar N, Leonard H, Pereira G. The effect of interpregnancy interval on birth outcomes. 2017 Scientific Meeting of the Australasian Epidemiology Association. Sydney NSW; 28-30 September 2017.

7

18. REGAN AK, Mak DB, Effler PV. Uptake of influenza and pertussis vaccines during pregnancy. 2016 Public Health Association of Australia National Immunisation Conference. Brisbane, QLD; 8 June 2016.

19. REGAN AK, Bloomfield LB, Blyth CC, Richmond PC, Effler PV. The safety of maternal vaccination in Australia. 2016 Public Health Association of Australia National Immunisation Conference. Brisbane QLD; 8 June 2016.

20. REGAN AK, Mak DB, Moore HC, Tracey L, Saker R, Jones C, Effler PV. Surveillance of antenatal vaccination in Western Australia. 2015 Communicable Disease Control Conference. Brisbane QLD; 1 June 2015.

21. REGAN AK, Peters I, Effler PV. Use of data extraction from general practice for measuring influenza vaccine uptake and effectiveness. 2015 Communicable Disease Control Conference. Brisbane QLD; 1 June 2015.

22. REGAN AK, Moore HC, de Klerk N, Shellam G, Effler PV. Lower rates of poor perinatal health outcomes following maternal influenza vaccination. 3rd Population Health Congress. Hobart TAS; 8 September 2015.

23. REGAN AK, Gibbs R, Peters I, Effler PV. Monitoring influenza vaccine coverage and effectiveness using electronic health record extraction from general practice. 3rd Population Health Congress. Hobart TAS; 8 September 2015.

24. REGAN AK, Mak DB, Moore HC, Tracey L, Saker R, Jones C, Effler PV. Validity of antenatal influenza vaccination surveillance systems in Western Australia. 3rd Population Health Congress. Hobart TAS; 8 September 2015.

25. REGAN AK, de Klerk N, Moore HC, Omer SB, Effler PV. The effectiveness of maternal influenza vaccination in Australia. 11th Australian Influenza Symposium. Geelong VIC; 13 October 2015.

26. REGAN AK, Blyth CC, Richmond PC, Effler PV. Use of mobile phone technology to monitor the safety of vaccines given during pregnancy. 2014 Annual Scientific Meeting of the Australasian Epidemiology Association. Auckland, New Zealand; 10 October 2014.

27. REGAN AK, Blyth CC, Richmond PC, Effler PV. Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. 9th Annual Influenza Symposium. Sydney NSW; 8 October 2013.

28. McCLAVE AK, McKnight ER, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. American Public Health Association 137th Annual Meeting and Exposition. Philadelphia PA; 11 November 2009.

29. McCLAVE AK, Strine T, Dube SR. Associations between health-related quality of life and smoking status among a large sample of U.S. adults. Behavior Risk Factor Surveillance System Conference. Orlando FL; 2 June 2008.

WORKSHOPS SELECTED FROM ABSTRACT:

1. REGAN AK, Dobson A. Early Career Researcher Workshop: Addressing exposure misclassification when using linked administrative data sources. 2014 Annual Scientific Meeting of the Australasian Epidemiology Association. Auckland, New Zealand; 10 October 2014.

2. McCLAVE AK, Berkowitz J, London J, Pechacek T. Understanding smokeless tobacco users and how to reach them. 2009 National Conference on Tobacco or Health. Phoenix AZ; 11 June 2009.

INVITED PRESENTATIONS:

1. REGAN AK. Antenatal vaccine uptake among Aboriginal mothers in Australia. 7th International Meeting on Indigenous Child Health, Denver CO; 4-6 April 2017.

8

2. REGAN AK. The PREVENT Network: An international cohort to measure influenza vaccine effectiveness in pregnant women. 12th Australian Influenza Symposium, Melbourne VIC; 5 November 2017.

3. REGAN AK. The safety of maternal immunisation. SA Vaccinology Update. Adelaide SA; November 2014.

4. REGAN AK. Surveillance and use of new smokeless tobacco in the US. 6th National Summit on Smokeless and Spit Tobacco. 10 May 2011.

CONFERENCE ORGANIZATION:

Co-Convener. 2018 Annual Scientific Meeting of the Australasian Epidemiology Association, Perth, Western Australia; 24-26 Oct 2018.

SESSION CHAIR:

Vaccine-Preventable Diseases. 16th PHAA National Immunisation Conference, Adelaide SA, 6 June 2018.

PSANZ Hot Topics. 2018 Annual Scientific Congress of the Perinatal Society of Australia & New Zealand. Auckland, New Zealand; 25 March 2018.

ABSTRACT REVIEWER:

2018 Annual Scientific Meeting of the Australasian Epidemiological Association

16th Public Health Association of Australia National Immunisation Conference (2018)

2018 Annual Congress of the Perinatal Society of Australia & New Zealand

2017 Annual Scientific Meeting of the Australasian Epidemiological Association

2017 Annual Congress of the Perinatal Society of Australia & New Zealand

15th Public Health Association of Australia Immunisation (2016)

3rd Population Health Congress (2015)

14th Public Health Association of Australia Immunisation (2014)

RESEARCH FUNDING

NATIONAL COMPETITIVE RESEARCH FUNDING - PI:

2018-2022 National Health & Medical Research Council Project Grant GNT1141510

AMOUNT: $676,333

TITLE: Links2HealthierBubs: Influenza and pertussis vaccine effectiveness and safety in pregnancy

2018-2022 National Health & Medical Research Council Early Career Fellowship GNT1138425

AMOUNT: $322,952

TITLE: Informing vaccination strategies for pregnant women through linked population health data

REGIONAL COMPETITIVE RESEARCH FUNDING - PI:

2018-2019 New Independent Researcher Infrastructure Support Award (Department of Health Western Australia)

AMOUNT: $15,000

TITLE: N/A

9

2018-2019 Wesfarmers Center of Vaccines & Infectious Diseases Seed Funding (Telethon Kids Institute)

AMOUNT: $23,763

TITLE: Text2VaxMums: Evaluating the potential use of SMS reminders for improving immunisation coverage among Australian pregnant women

2018 RAINE Brightspark Research Collaboration Awards

AMOUNT: $5,000

TITLE: An international cohort study measuring child health following maternal immunization

DEMAND-DRIVEN RESEARCH FUNDING – CO-PI:

2016-2017 Centers for Disease Control & Prevention / Abt Associates Subcontract

AMOUNT: $62,767

TITLE: Multi-Country investigation of influenza vaccine effectiveness in preventing hospitalization and other adverse outcomes associated with influenza among pregnant women

REGIONAL COMPETITIVE RESEARCH FUNDING – CO-INVESTIGATOR:

2018-2019 Curtin Institute for Computation Operational Research Support

AMOUNT: $23,582

TITLE: A pilot study for Australia’s first risk assessment system for perinatal mortality and morbidity

2018-2019 Curtin University School of Economics and Finance Grant Success Panel Seed Funding

AMOUNT: $5,000

TITLE: The determinants and longer term effects of childhood immunisations

NATIONAL COMPETITIVE RESEARCH FUNDING - PI:

2018-2022 National Health & Medical Research Council Project Grant GNT1141510

AMOUNT: $676,333

TITLE: Links2HealthierBubs: Influenza and pertussis vaccine effectiveness and safety in pregnancy

STUDENT SUPERVISION

PHD - PRINCIPAL SUPERVISOR:

July 2018- Mr Damien Foo (Curtin University)

TITLE: A longitudinal linked cohort study evaluating paediatric health outcomes following exposure to vaccine during pregnancy.

Nov 2017- Dr Ravisha Srinivasjois (Curtin University)

TITLE: Risk of future mortality and morbidity by gestational age at birth.

10

Sept 2017- Mr Amanuel Gebremedhin (Curtin University)

TITLE: Setting evidence-based recommendations for interpregnancy intervals in high-income countries based on obstetric and sociodemographic context.

Sept 2017- Mr Amanuel Gebremedhin (Curtin University)

TITLE: Setting evidence-based recommendations for interpregnancy intervals in high-income countries based on obstetric and sociodemographic context.

MASTERS - PRINCIPAL SUPERVISOR:

Feb 2018- Dr Hollie Cooke (Curtin University)

TITLE: Evaluating the perinatal impacts of seasonal influenza vaccination in early pregnancy.

Feb-May 2017 Ms Virginia Becker (Curtin University)

TITLE: Respiratory syncytial virus (RSV) in pregnancy: A review of current supporting evidence for RSV vaccination during the antenatal period

Feb-May 2017 Ms Joanne Carson (Curtin University)

TITLE: Rapid review of Mycoplasma genitalium prevalence, risk factors, morbidity and antibiotic resistance to guide future surveillance in Australia

MASTERS – CO-SUPERVISOR:

Jan-Dec 2016 Dr Kennia Lotter (University of Notre Dame)

TITLE: Antenatal influenza and pertussis vaccine uptake among Aboriginal mothers in Western Australia

Feb-May 2016 Ms Jenny Vo (University of Western Australia)

TITLE: Uptake and predictors of pertussis vaccines in pregnant women in Western Australia

Feb-May 2015 Dr Ngibo Mbuta (University of Western Australia)

TITLE: Trends in varicella and herpes zoster infection following the introduction of a varicella vaccination program

TEACHING

COURSE COORDINATION:

2019- Reproductive & Perinatal Epidemiology (PHEB662), Texas A&M University School of Public Health

GUEST LECTURES:

2018 Issues in Women’s Reproductive Health (IMED 2208), University of Western Australia School of Biomedical Sciences

TITLE: Overview of maternal immunisation programs

11

LABORATORY DEMONSTRATION:

2013-2015 Antimicrobial Agents (MICR5833), University of Western Australia School of Biomedical Sciences

2013-2015 Introduction to Infectious Diseases (MICR2209), University of Western Australia School of Biomedical Sciences

2013-2015 Clinical Diagnostic Microbiology (MICR5503), University of Western Australia School of Biomedical Sciences

PRIZES & AWARDS

2018 Best Oral Presentation in Epidemiology, Perinatal Society of Australia & New Zealand ($1,000)

2017 Aileen Plant Memorial Prize in Infectious Disease Epidemiology ($1,000) 2017 Friends of the Institute Collaboration Award ($2,400) 2015 Western Australia Branch of Public Health Association of Australia Conference Award

($1,600) 2015 Allegra Scafidas Development Award ($5,000) 2014 Australasian Epidemiology Association Early Career Research Workshop Award ($1,000) 2014 International Epidemiology Association Conference 3rd Prize in Student Posters 2013 University of Western Australia 2nd Prize in Masters of Infectious Diseases Coursework 2013 Friends of the Institute Travel Award ($1,600) 2012 Perth Epidemiology Group Meeting, Best Oral Presentation 2012 Stan & Jean Perron Top-Up Scholarship ($5,000 pa)

PEER REVIEW INVOLVEMENT

EDITORIAL RESPONSIBILITIES:

2018- Associate Editor, BMC Pregnancy and Childbirth

PEER REVIEW FOR JOURNALS:

2018- Clinical Microbiology & Infection 2018- Public Health Research & Practice 2018- Expert Review of Vaccines 2018- South African Medical Journal 2017- Lancet Infectious Diseases 2016- Australia & New Zealand Journal of Obstetrics & Gynaecology 2016- Paediatric & Perinatal Epidemiology 2015- BMC Infectious Diseases 2015- BMC Pregnancy & Childbirth 2015- PLoS One 2014- Vaccine 2007- Nicotine & Tobacco Research 2007- American Journal of Preventive Medicine

12

GRANT REVIEW PANELS:

2016-2018 Primary spokesperson, Wesfarmers Seed Funding Panel 2018 External Assessor, Sir Charles Gairdner 2018-19 Annual RAC Grant Funding 2016 External Assessor, Royal Adelaide Hospital Research Fund

PROFESSIONAL & COMMITTEE MEMBERSHIPS

PROFESSIONAL MEMBERSHIPS:

2018- Society for Epidemiology Research 2018- Society for Perinatal Epidemiology Research 2016- Perinatal Society of Australia & New Zealand 2013- International Society for Influenza & Other Respiratory Viruses 2012- Australasian Epidemiology Association 2012- International Epidemiology Association (Lifetime Member) 2012-2017 Public Health Association of Australia 2006-2011 American Public Health Association

COMMITTEE MEMBERSHIPS:

2017- Perinatal Society of Australia & New Zealand Academy Member

SKILLS & ACHIEVEMENTS

H-index 17

i10-index 28

55 peer-reviewed publications with 1,631 total citations

Proficient in SAS, STATA, and R

Trained in project management and research leadership